Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 110 participants.

Also called NCT01999829

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 110 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01999829
Other papers using this trial's data
  • Peri-operative oral caffeine does not prevent postoperative atrial fibrillation after heart valve surgery with cardiopulmonary bypass: A randomised controlled clinical trial European journal of anaesthesiology, 2018-12 DOI, PubMed 29702502

Courtesy of the U.S. National Library of Medicine.

Start date
(registry gives no type) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
France (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01999829. Randomized; quadruple masking; primary purpose treatment. Start 2013-10 (registry gives no type); primary completion 2016-06 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Prevention of Atrial Fibrillation Following Valvular Replacement With Cardiopulmonary Bypass: a Prospective, Randomized Clinical Study Comparing Oral Caffeine With Placebo
Intervention (Drug)
citrate of caffeine
Intervention (Drug)
placebo
Lead sponsor
Assistance Publique Hopitaux De Marseille (class: other)

Record details

Record id
cardio:ct-nct01999829
Content hash
5a17b04f8542532a84cba7ba1c9c6b31f6263149ec79d2f2e34f95dde1c31152